Accessibility Remediation
If you are unable to use this item in its current form due to accessibility barriers, you may request remediation through our remediation request form.
Authors
- F. Abad-Franch, Pathogen Molecular Biology and Biochemistry Unit, Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London WC 1E 7HT, UK
- F. Noireau, Institut de Recherche pour le Developpement (IRD) and Instituto Oswaldo Cruz, Laboratório Nacional e Internacional de Referênda em Taxonomia de Triatomíneos, avenida Brasil 4365, 21045-900 Rio de Janeiro, Brazil
- A. Paucar C., University of Nebraska - Lincoln
- H. M. Aguilar V., Unidad de Medicina Tropical, Instituto ‘Juan Cesar Garcia,’ CP 17-1106292 Quito, Ecuador
- C. Carpio C., Unidad de Medicina Tropical, Instituto ‘Juan Cesar Garcia,’ CP 17-1106292 Quito, Ecuador
- J. Racines V., Instituto Nacional de Higiene y Medicina Tropical ‘Leopoldo Izquieta Pérez Zona Norte, Iquique 2045 y Yaguachi, Quito, Ecuador
Date of this Version
November 2000
Abstract
Chagas disease is a major public health challenge for most Latin American countries. An initiative for the coordinated control of Chagas disease transmission throughout the Andean countries was launched in 1997. Since the early 1990s, control measures based on elimination of domestic/peridomestic triatomine colonies and screening of donor blood by serological testing have resulted in a reduction in incidence of ~70% in the Southern Cone countries (WHO, 1991; Dias & Schofield, 1999; Moncayo, 1999; WHO/CTD, 2000).
DOWNLOADS
Since March 05, 2008
COinS
Comments
Published in Transactions of The Royal Society of Tropical Medicine and Hygiene 94:6 (November/December 2000), pp. 629–630. Copyright © 2000 Royal Society of Tropical Medicine and Hygiene; published by Elsevier. Used by permission. http://www.sciencedirect.com/science/journal/00359203